Work

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease

Year: 2003

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2003.09.026

Authors: Ralph G Zinner, Bonnie S Glisson, Frank V Fossella, Katherine M.W Pisters, Merril S Kies, Pamela M Lee, Erminia Massarelli, Bradley Sabloff, Herbert A Fritsche, Jae Y Ro, Nelson G Ordonez, Hai T Tran, Ying Yang, Terry L Smith, Robert D Mass, Roy S Herbst

Institutions: The University of Texas MD Anderson Cancer Center, Genentech

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Food and Drug Administration, Genentech

OpenAlex ID: W2007010878

FWCI: 5.419

Cites: 53

Cited by: 127

Related to: 10